QBFM
EW icon

QS Batterymarch Financial Management’s Edwards Lifesciences EW Stock Holding History

QS Batterymarch Financial Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,608
Closed -$132K – 939
2014
Q1 		$132K Sell
10,608
-30,852
-74% -$356K ﹤0.01% 968
2013
Q4 		$455K Buy
41,460
+29,322
+242% +$331K 0.01% 717
2013
Q3 		$141K Sell
12,138
-450
-4% -$5.26K ﹤0.01% 933
2013
Q2 		$141K Buy
+12,588
New +$149K ﹤0.01% 935

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

QS Batterymarch Financial Management's EW Position: Q2 2014 in Review

QS Batterymarch Financial Management sold out of Edwards Lifesciences (EW) in Q2 2014, closing a stake of 10,608 shares — an estimated $132K sold.

QS Batterymarch Financial Management first reported a position in EW in Q2 2013 and held it in 4 quarters. The position peaked at $455K in Q4 2013. 429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • QS Batterymarch Financial Management reported no remaining Edwards Lifesciences position as of Q2 2014 after selling out during the quarter.
  • QS Batterymarch Financial Management sold 10,608 Edwards Lifesciences shares in Q2 2014, an estimated $132K.
  • QS Batterymarch Financial Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 4 quarters.
  • QS Batterymarch Financial Management's Edwards Lifesciences position peaked at $455K in Q4 2013.
  • 429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q2 2014, filed 14 Aug 2014.